Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Green KN, Demuro A, Akbari Y, Hitt BD, Smith IF, Parker I, Laferla FM. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. J Cell Biol. 2008 Jun 30;181(7):1107-16. PubMed Abstract

  
Comments on Paper and Primary News
  Comment by:  Charles Glabe, ARF Advisor
Submitted 5 July 2008  |  Permalink Posted 9 July 2008
  I recommend this paper

  Comment by:  Philip Landfield, Olivier Thibault
Submitted 11 July 2008  |  Permalink Posted 11 July 2008

Recent interesting and new findings by the LaFerla group (Green et al., 2008) add to the growing evidence that AD-related mutations may affect Ca2+ homeostasis, particularly through regulatory pathways controlling intracellular uptake and release mechanisms (e.g., Ca2+-induced Ca2+ release [CICR] via RyRs, ER leak, IP3Rs, SERCA). One note of caution emerging from these studies, however, is the wide diversity of specific cellular mechanisms reported to be sensitive to presenilins and AD-related mutations (Leissring et al., 2000; Stutzmann et al., 2004; Tu et al., 2006; Cheung et al., 2008; Dreses-Werringloer et al., 2008). This diversity raises the question of whether all of these actions reflect physiologically relevant effects on Ca2+ regulation or whether instead the differences might reflect interactions with the varied cell types and experimental conditions employed. In addition, the relationship of these AD mutation effects to alterations in Ca2+ regulation (e.g., increased CICR, L-type voltage-gated Ca2+ channels, afterhyperpolarization, etc.) that occur in normal...  Read more

  Primary News: Pump It Up—Presenilins Linked to ER SERCA Activity

Comment by:  Jacob Mack
Submitted 13 July 2008  |  Permalink Posted 15 July 2008
  I recommend this paper
Comments on Related News
  Related News: More Calcium News: Plaques Cause Dendrite Damage via Ion Overload

Comment by:  Carlos Villalobos
Submitted 7 August 2008  |  Permalink Posted 8 August 2008

I certainly like the idea that this season might go down in the Alzheimer research history as the summer of calcium, with four major studies recently forging new links between calcium problems in neurons and Alzheimer disease (AD). However, a major issue is how AD-related, deranged calcium signals lead to neuron dysfunction and death.

We have shown a few days ago (Sanz-Blasco et al., 2008) that Aβ oligomers (but not fibrils) promote Ca2+ influx into primary neurons (but not glia). This influx is followed by mitochondrial calcium overload as monitored by photon counting imaging of low-affinity aequorin targeted to mitochondria. The relevance of this finding is that prevention of mitochondrial calcium overload using low concentrations of mitochondrial uncoupler protects neurons against Aβ-induced ROS production, permeability transition, cytochrome c release, and apoptosis and cell death.

Moreover, we found that a series of carboxylic, non-steroidal anti-inflammatory drugs including R-flurbiprofen prevent the mitochondrial calcium overload, acting as mitochondrial...  Read more

  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:
For protein immunoblotting, Antibodies used in this study include αSERCA2b (F. Wuytack, Katholieke Universiteit Leuven, Leuven, Netherlands), CTF20 (EMD), and α-Actin (Sigma-Aldrich)
For Aβ ELISA, wells were probed with either HRPconjugated mouse monoclonal anti-Aβ 1-40 (BA27) (Takeda) or mouse monoclonal anti-Aβ 1-42 (BC05) (Takeda)
For immunoprecipitation, rabbit anti-PS1 (Cell Signaling Technology), PS2 (G. Thinakaran, University of Chicago, Chicago, IL), or p35 (Santa Cruz Biotechnology, Inc.) as a control.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad